Optimizing Treatment for Chronic Hepatitis C Patients with Hepatitis C Virus Genotype 1 Infection
博士 === 國立臺灣大學 === 臨床醫學研究所 === 103 === Chronic hepatitis C virus (HCV) infection, the leading cause of cirrhosis, hepatic decompensation and hepatocellular carcinoma (HCC), affects approximately 3% of the individuals worldwide. Peginterferon (PEG-IFN) plus ribavirin (RBV) therapy (PR) is one of the c...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2015
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/16276864205464839418 |